Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Evaluation of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration

Next Previous
X
Search
Trial Profile

Evaluation of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 05 Aug 2020

Price :

$35 *

Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Abicipar pegol (Primary)
  • Indications Wet age-related macular degeneration
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms MAPLE
  • Sponsors Allergan

    • Most Recent Events

    • 02 Apr 2019 According to an Allergan Media Release, results of this study enabled to assess improvements to the manufacturing process for abicipar. Additional data from the MAPLE study will be presented at a scientific conference later in 2019.
    • 02 Apr 2019 Topline safety results published in an Allergan Media Release
    • 02 Apr 2019 Status changed from recruiting to completed.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top